Browsing Tag
Dexcom
6 posts
Insulet Omnipod 6 data puts PODD back in focus as automated insulin delivery moves toward type 2 diabetes
Read how Insulet Omnipod 6 data could reshape automated insulin delivery, type 2 diabetes care and PODD stock sentiment. Find out what changes next in 2026.
DexCom (DXCM) gains strategic evidence edge as CONNECT study targets broader diabetes market
Find out how DexCom’s CONNECT study could expand CGM use in non-insulin Type 2 diabetes and reshape DXCM’s growth outlook.
MiniMed IPO: Medtronic (NYSE: MDT) to separate diabetes business with Nasdaq filing under MMED
Medtronic files IPO for MiniMed, its diabetes business. Find out what the Nasdaq listing means for the company’s strategy, margins, and the diabetes tech sector.
Biolinq’s needle-free glucose monitor wins FDA nod — Could this disrupt Dexcom and Abbott’s CGM dominance?
Biolinq Shine earns FDA de novo clearance as the first needle-free CGM, challenging Dexcom and Abbott in the diabetes tech market.
Dexcom’s 15-day G7 gets FDA nod—Could this be the game-changer for glucose monitoring and stock momentum?
Dexcom’s FDA-approved G7 15 Day CGM delivers record wear time and accuracy—read how it’s transforming diabetes care and investor sentiment.
Revolutionizing diabetes care: Dexcom G7 CGM System gets Health Canada nod
Dexcom, a notable player in real-time continuous glucose monitoring (rtCGM) globally, confirmed today that Health Canada has given…